1 |
Lee SD. A Study of Vitiligo on the Oriental and Western Medicine Approch. The Journal of Wonkwang Oriental Medicine. 1991;1(1): 61-9.
|
2 |
Choi KH, Park JH, Ro Ys, Treatment of Vitiligo with 308-nm xenon-chloride Excimer Laser: Therapeutic Efficacy of Different Initial Doses according to Traetment Areas. J Dermatol. 2004;31:284-92.
DOI
|
3 |
Park SG, Lee GS, Park YK. Therapeutic Effect of Narrow-band UVB Phototheraphy in the Treatment of Vitiligo. Korean J Dermatol. 2004;42:1121-9.
|
4 |
Hong KC, Kim MS, Lee UH, Park HS. Therapeutic Effects of 308nm Eximer Laser in the Treatment of vitiligo Patients: A single Center Study in Korea. Korean J Dermatol. 2013;51:755-62.
|
5 |
Lee SD. A Documentary Study on Herd, Dmgs used for Vitiligo:With an Emphasis on Classifying Kinds, Excess and Weakness Syndrome, the Changes of Medical Methods and Factors by each Epoch Mentioned in the Relative Documentary Records. J Korean Orient Med. 1995;16(2):44-61.
|
6 |
Ji SY, Kwon YK, Shin SK. A Study of Vitiligo on the Oriental and Western Medicine. The Journal of Jeahan Oriental Medical Academy. 1999;4(1):262-85
|
7 |
Lee SD. A Study of Vitiligo on the Oriental and Western Medicine Approch. The Journal of Wonkwang Oriental Medicine. 1992;2(1): 214-20.
|
8 |
Kim Jung Ho, Chae,BY. Clinical study on patient with vitiligo. The Journal of Korean Oriental Medicine. 1987;8(2):90-4.
|
9 |
Jung JH, Seo HS. One Case Report of Vitiligo. J Korean Med Ophthalmol Otolaryngol Dermatol. 2005;18(3):121-6.
|
10 |
Koga M. Vitiligo; a new classification and therapy. Br J Dermatol 1977;97:255-61.
DOI
|
11 |
Jeon EK, Park YO, Seo YJ, Lee JH, Park JK. Assessment of the Quality of Life in Vitiligo Patients. Korean J Dermatol. 2008;46:874-80.
|
12 |
Lee JH, Kim SY. Four cases of vitiligo patients treated by Oriental medical treatment who have experienced Eximer Laser treatment. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014;27(3):205-12.
DOI
|
13 |
Ortonne JP, Mosher DB, Fitzpatrick TB. Hypomelanotic disorders: vitiligo and other hypomelanoses fo hair and skin. 6th ed. New York: Plenum, 1983:120-310.
|
14 |
Lerner AB. Vitilgo. J Invest Dermatol 1959;32:285-310.
DOI
|
15 |
Masher DB, Fitzpatrick TB, Ortonne JP, Abnormalities of pigmentation. Fitzpatrick TB, Eisen AZ, Wolff K, et al(eds). Dermatology in General Medicine, ed 2. New York: McGraw-Hill Book, 1979;582-90.
|
16 |
Behl PN, Bhatia RK. 400 cases of vitiligo:a clinicotherapeutic analysis. Indian J Dermatol 1972;17:51-56.
|
17 |
Betterie C, Caretto A, De Zio A, Pedini B, Velle-Fornasa. Incidence and significance of organ-specific autoimmune disorder in patients with vitiligo. Dermatologica 1985;171: 419-23.
DOI
|
18 |
Bettler C, Careto A, De Zio A, Pedini B, Velle-Fornasa C, Cecchetto A, et al. Incidence and significance of organspecific antoimmune disorder in patients with vitiligo. Dermatologica 1985;171:419-23.
DOI
|
19 |
Koga M. Vitiligo: a new classification and therapy. Br J Dermatol 1977;97:255-61.
DOI
|
20 |
Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanoses and hypermelanoses, In: Freedberg IM, Eisen AZ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill Book, 1999;945-1017.
|